Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut.
Redshift Technologies, New York, New York.
Fertil Steril. 2018 Nov;110(6):1081-1088.e1. doi: 10.1016/j.fertnstert.2018.07.016.
To assess the attitudes of Society for Assisted Reproductive Technology (SART) members regarding expanding insurance coverage for patients seeking assisted reproductive technologies (ART) and identify some of the factors that may influence such attitudes.
An anonymous online 14-question survey of SART membership; 1,556 surveys were sent through the SART Research Portal from June to December 2017. Questions were incremental in scope, beginning with expanding insurance coverage for ART for vulnerable populations (e.g., fertility preservation for cancer, couples with same recessive gene, fertility preservation for transgender individuals) to extending coverage to include patients who were uninsured for ART. Additional questions assessed attitudes about assuming some fiscal responsibility if mandated insurance were contingent on elective single-embryo transfer (eSET) and lower charges in anticipation of increased number of cases.
Not applicable.
PATIENT(S): Not applicable.
INTERVENTION(S): Not applicable.
MAIN OUTCOME MEASURE(S): Specific response to 14 survey questions.
RESULT(S): The overall response rate was 43.4% (675/1,556). A large majority (>95%) favored insurance for fertility preservation for cancer patients and for avoidance of genetic disorders; 62.3% were supportive of infertility insurance coverage for transgender patients; 78% supported expanding insurance for the broadest segment of the general uninsured population; 76.7% supported expanding insurance contingent on eSET; and 51.3% would consider expanding insurance contingent on lowering charge per cycle in general, but only 23% responded as to what lower charge would be acceptable. Three of four factors were shown by multivariable logistic regression to be predictive of attitudes willing to expand insurance: practice setting (academic > hybrid > private), practicing in a mandated state, and higher annual volume of cases (>500 cycles); these had significant increased adjusted odds ratios ranging from 1.7 to 2.9. A fourth factor, the professional role one had in the practice, was not found to be of significant predictive value.
CONCLUSION(S): The great majority of respondents were supportive of expanding insurance for specific segments of vulnerable populations with special needs and for the population who are presently uninsured. Furthermore, the majority of respondents would consider expanding insurance coverage contingent on age-appropriate eSET but have concerns about reduced reimbursement. Those most likely to be willing to expand insurance are those who practice in an academic setting or a mandated state and/or have a high annual volume of cases.
评估辅助生殖技术协会(SART)成员对扩大寻求辅助生殖技术(ART)患者保险范围的态度,并确定可能影响此类态度的一些因素。
对 SART 成员进行了一项匿名的在线 14 个问题调查;2017 年 6 月至 12 月,通过 SART 研究门户向 1556 名调查者发送了调查。问题的范围逐渐扩大,首先是扩大对弱势群体的 ART 保险范围(例如,癌症患者的生育力保存、携带相同隐性基因的夫妇、变性个体的生育力保存),再到将保险范围扩大到没有 ART 保险的患者。其他问题评估了如果强制性保险取决于选择性单胚胎移植(eSET),以及为预期增加的病例数量降低费用,是否要承担一些财政责任的态度。
不适用。
不适用。
不适用。
对 14 个调查问题的具体答复。
总体回复率为 43.4%(675/1556)。绝大多数(>95%)赞成为癌症患者的生育力保存和避免遗传疾病提供保险;62.3%支持为变性患者提供不孕症保险;78%支持为最广泛的一般无保险人群扩大保险范围;76.7%支持在 eSET 条件下扩大保险范围;51.3%会考虑在一般情况下扩大保险范围,条件是降低每个周期的费用,但只有 23%的人回答可以接受的降低费用是多少。多元逻辑回归显示,有四个因素可预测愿意扩大保险范围的态度:实践环境(学术机构>混合>私人)、在强制州执业,以及每年的案例量较高(>500 个周期);这些因素的调整后优势比有显著增加,范围从 1.7 到 2.9。第四个因素,即一个人在实践中的专业角色,没有被发现具有显著的预测价值。
绝大多数调查对象支持为有特殊需求的弱势群体的特定群体和目前没有保险的人群扩大保险范围。此外,大多数调查对象都认为在适当年龄的 eSET 条件下扩大保险范围是可以考虑的,但对报销减少表示担忧。最有可能愿意扩大保险范围的是那些在学术机构或强制州执业的人,或者每年的病例量较高的人。